The progression of the tubulointerstitial fibrosis driven by stress-induced "proliferation-death" vicious circle

Medical Hypotheses

Volumn 82, Issue 6, 2014, Pages 643-647

  Chen, Bi cheng ^a   Bai, Yong heng ^a   Tang, Li li ^a   Wang, Beng quan ^a   Liu, Biao ^a   Cai, Yong ^b   Peng, Xia ^b   Yang, Yi rong ^b   Zheng, Shao ling ^b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; RAPAMYCIN; ROSCOVITINE; SURAMIN; VITAMIN D; SIGNAL PEPTIDE;

ARTICLE; CELL CYCLE; CELL DAMAGE; CELL DEATH; CELL PROLIFERATION; CYTOKINE RELEASE; DRUG TARGETING; ENDOCRINE SYSTEM; EPITHELIUM CELL; HUMAN; HYPERTENSION; HYPOXIA; INFLAMMATION; ISCHEMIA; KIDNEY FIBROSIS; KIDNEY TUBULE EPITHELIUM; MOLECULAR BIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; RENAL PROTECTION; STRESS; TUBULOINTERSTITIAL FIBROSIS; COMPLICATION; FIBROSIS; INTERSTITIAL NEPHRITIS; KIDNEY TUBULE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REGENERATION;

CELL DEATH; CELL PROLIFERATION; EPITHELIAL CELLS; FIBROSIS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY TUBULES; NEPHRITIS, INTERSTITIAL; REGENERATION;

EID: 84899631233     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.01.014     Document Type: Article

References (89)

1. Lange-Sperandio B., Forbes M.S., Thornhill B., Okusa M.D., Linden J., Chevalier R.L. A2A adenosine receptor agonist and PDE4 inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy. Nephron Exp Nephrol 2005, 100(3):e113-123.
2. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006, 17(1):17-25.
3. Yang H., Fogo A.B. Cell senescence in the aging kidney. J Am Soc Nephrol 2010, 21(9):1436-1439.
4. Ding G., Franki N., Kapasi A.A., Reddy K., Gibbons N., Singhal P.C. Tubular cell senescence and expression of TGF-beta1 and p21(WAF1/CIP1) in tubulointerstitial fibrosis of aging rats. Exp Mol Pathol 2001, 70(1):43-53.
5. Aresu L., Rastaldi M.P., Scanziani E., Baily J., Radaelli E., Pregel P., et al. Epithelial-mesenchymal transition (EMT) of renal tubular cells in canine glomerulonephritis. Virchows Arch 2007, 451(5):937-942.
6. Rhyu D.Y., Yang Y., Ha H., Lee G.T., Song J.S., Uh S.T., et al. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 2005, 16(3):667-675.
7. van Kooten C., Daha M.R., van Es L.A. Tubular epithelial cells: a critical cell type in the regulation of renal inflammatory processes. Exp Nephrol 1999, 7(5-6):429-437.
8. Lin F., Cordes K., Li L., Hood L., Couser W.G., Shankland S.J., et al. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2003, 14(5):1188-1199.
9. Maeshima A., Yamashita S., Nojima Y. Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney. J Am Soc Nephrol 2003, 14(12):3138-3146.
10. Smith P.L., Buffington D.A., Humes H.D. Kidney epithelial cells. Methods Enzymol 2006, 419:194-207.
11. Maeshima A., Sakurai H., Nigam S.K. Adult kidney tubular cell population showing phenotypic plasticity, tubulogenic capacity, and integration capability into developing kidney. J Am Soc Nephrol 2006, 17(1):188-198.
12. Asanuma H., Meldrum D.R., Meldrum K.K. Therapeutic applications of mesenchymal stem cells to repair kidney injury. J Urol 2010, 184(1):26-33.
13. Bi B., Schmitt R., Israilova M., Nishio H., Cantley L.G. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 2007, 18(9):2486-2496.
14. Duffield J.S., Park K.M., Hsiao L.L., Kelley V.R., Scadden D.T., Ichimura T., et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 2005, 115(7):1743-1755.
15. Gnecchi M., He H., Liang O.D., Melo L.G., Morello F., Mu H., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005, 11(4):367-368.
16. Togel F., Hu Z., Weiss K., Isaac J., Lange C., Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005, 289(1):F31-42.
17. Lin F., Moran A., Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 2005, 115(7):1756-1764.
18. Anglani F., Mezzabotta F., Ceol M., Cristofaro R., Del Prete D., D'Angelo A. The regenerative potential of the kidney: what can we learn from developmental biology?. Stem Cell Rev 2010, 6(4):650-657.
19. Bao J., Tu Z., Sun H., Luo G., Yang L., Song J., et al. Identification of renal potential progenitor/stem cells that participate in the renal regeneration processes of kidney allograft fibrosis. Nephrology (Carlton) 2008, 13(6):500-507.
20. Oliver J.A., Klinakis A., Cheema F.H., Friedlander J., Sampogna R.V., Martens T.P., et al. Proliferation and migration of label-retaining cells of the kidney papilla. J Am Soc Nephrol 2009, 20(11):2315-2327.
21. Kitamura S., Yamasaki Y., Kinomura M., Sugaya T., Sugiyama H., Maeshima Y., et al. Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney. FASEB J 2005, 19(13):1789-1797.
22. Bastos A.P., Piontek K., Silva A.M., Martini D., Menezes L.F., Fonseca J.M., et al. Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia/reperfusion. J Am Soc Nephrol 2009, 20(11):2389-2402.
23. Humphreys B.D., Valerius M.T., Kobayashi A., Mugford J.W., Soeung S., Duffield J.S., et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008, 2(3):284-291.
24. Bonventre J.V. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 2003, 14(Suppl 1):S55-61.
25. Lechler P., Wu X., Bernhardt W., Campean V., Gastiger S., Hackenbeck T., et al. The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney. Am J Pathol 2007, 171(5):1483-1498.
26. Maeshima A. Label-retaining cells in the kidney: origin of regenerating cells after renal ischemia. Clin Exp Nephrol 2007, 11(4):269-274.
27. Loverre A., Capobianco C., Ditonno P., Battaglia M., Grandaliano G., Schena F.P. Increase of proliferating renal progenitor cells in acute tubular necrosis underlying delayed graft function. Transplantation 2008, 85(8):1112-1119.
28. Inguaggiato P., Gonzalez-Michaca L., Croatt A.J., Haggard J.J., Alam J., Nath K.A. Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int 2001, 60(6):2181-2191.
29. Megyesi J., Safirstein R.L., Price P.M. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 1998, 101(4):777-782.
30. Megyesi J., Andrade L., Vieira J.M., Safirstein R.L., Price P.M. Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure. Kidney Int 2001, 60(6):2164-2172.
31. Price P.M., Safirstein R.L., Megyesi J. Protection of renal cells from cisplatin toxicity by cell cycle inhibitors. Am J Physiol Renal Physiol 2004, 286(2):F378-384.
32. Yamashita S., Maeshima A., Nojima Y. Involvement of renal progenitor tubular cells in epithelial-to-mesenchymal transition in fibrotic rat kidneys. J Am Soc Nephrol 2005, 16(7):2044-2051.
33. Park H.C., Yasuda K., Ratliff B., Stoessel A., Sharkovska Y., Yamamoto I., et al. Postobstructive regeneration of kidney is derailed when surge in renal stem cells during course of unilateral ureteral obstruction is halted. Am J Physiol Renal Physiol 2010, 298(2):F357-364.
34. Zerbini G., Piemonti L., Maestroni A., Dell'Antonio G., Bianchi G. Stem cells and the kidney: a new therapeutic tool?. J Am Soc Nephrol 2006, 17(4 Suppl. 2):S123-126.
35. Thomas G.L., Yang B., Wagner B.E., Savill J., El Nahas A.M. Cellular apoptosis and proliferation in experimental renal fibrosis. Nephrol Dial Transplant 1998, 13(9):2216-2226.
36. Prasad S., McDaid J.P., Tam F.W., Haylor J.L., Ong A.C. Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury. Am J Pathol 2009, 175(4):1493-1503.
37. Fesenko I., Franklin D., Garnett P., Bass P., Campbell S., Hardyman M., et al. Stem cell marker TRA-1-60 is expressed in foetal and adult kidney and upregulated in tubulo-interstitial disease. Histochem Cell Biol 2010, 134(4):355-369.
38. Forbes M.S., Thornhill B.A., Minor J.J., Gordon K.A., Galarreta C.I., Chevalier R.L. Fight-or-flight: murine unilateral ureteral obstruction causes extensive proximal tubular degeneration, collecting duct dilatation, and minimal fibrosis. Am J Physiol Renal Physiol 2012, 303(1):F120-129.
39. Cachat F., Lange-Sperandio B., Chang A.Y., Kiley S.C., Thornhill B.A., Forbes M.S., et al. Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. Kidney Int 2003, 63(2):564-575.
40. Happe H, Leonhard WN, van der Wal A, van de Water B, Lantinga-van Leeuwen IS, Breuning MH, de Heer E, Peters DJ. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum Mol Genet 2009; 18(14): 2532-2542.
41. Lasagni L., Romagnani P. Glomerular epithelial stem cells: the good, the bad, and the ugly. J Am Soc Nephrol 2010, 21(10):1612-1619.
42. Yuan L., Wu M.J., Sun H.Y., Xiong J., Zhang Y., Liu C.Y., et al. VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol 2010, 300(1):207-218.
43. Elkhafif N., El Baz H., Hammam O., Hassan S., Salah F., Mansour W., et al. CD133(+) human umbilical cord blood stem cells enhance angiogenesis in experimental chronic hepatic fibrosis. APMIS 2011, 119(1):66-75.
44. Asanuma H., Vanderbrink B.A., Campbell M.T., Hile K.L., Zhang H., Meldrum D.R., et al. Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J Surg Res 2010, 168(1):e51-9.
45. Semedo P, Correa-Costa M, Antonio Cenedeze M, Maria Avancini Costa Malheiros D, Antonia dos Reis M, Shimizu MH, Seguro AC, Pacheco-Silva A, Saraiva Camara NO. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 2009; 27(12): 3063-3073.
46. Burst V.R., Gillis M., Putsch F., Herzog R., Fischer J.H., Heid P., et al. Poor cell survival limits the beneficial impact of mesenchymal stem cell transplantation on acute kidney injury. Nephron Exp Nephrol 2010, 114(3):e107-116.
47. Semedo P., Palasio C.G., Oliveira C.D., Feitoza C.Q., Goncalves G.M., Cenedeze M.A., et al. Early modulation of inflammation by mesenchymal stem cell after acute kidney injury. Int Immunopharmacol 2009, 9(6):677-682.
48. Kelley R, Werdin ES, Bruce AT, Choudhury S, Wallace SM, Ilagan RM, Cox BR, Tatsumi-Ficht P, Rivera EA, Spencer T, Scott Rapoport H, Wagner BJ, Guthrie K, Jayo MJ, Bertram TA, Presnell SC. Tubular cell-enriched subpopulation of primary renal cells improves survival and augments kidney function in rodent model of chronic kidney disease. Am J Physiol Renal Physiol 2010; 299(5): F1026-1039.
49. Yoo JH, Park C, Jung DI, Lim CY, Kang BT, Kim JH, Park JW, Park HM. In Vivo Cell Tracking of Canine Allogenic Mesenchymal Stem Cells Administration via Renal Arterial Catheterization and Physiopathological Effects on the Kidney in Two Healthy Dogs. J Vet Med Sci 2010.
50. Thirabanjasak D., Tantiwongse K., Thorner P.S. Angiomyeloproliferative lesions following autologous stem cell therapy. J Am Soc Nephrol 2010, 21(7):1218-1222.
51. Dalakas E., Newsome P.N., Boyle S., Brown R., Pryde A., McCall S., et al. Bone marrow stem cells contribute to alcohol liver fibrosis in humans. Stem Cells Dev 2010, 19(9):1417-1425.
52. Alison M.R., Islam S., Lim S. Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J Pathol 2009, 217(2):282-298.
53. Vercauteren S.R., Ysebaert D.K., De Greef K.E., Eyskens E.J., De Broe M.E. Chronic reduction in renal mass in the rat attenuates ischemia/reperfusion injury and does not impair tubular regeneration. J Am Soc Nephrol 1999, 10(12):2551-2561.
54. Price P.M., Yu F., Kaldis P., Aleem E., Nowak G., Safirstein R.L., et al. Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2. J Am Soc Nephrol 2006, 17(9):2434-2442.
55. Ophascharoensuk V., Fero M.L., Hughes J., Roberts J.M., Shankland S.J. The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nat Med 1998, 4(5):575-580.
56. Topcu S.O., Celik S., Erturhan S., Erbagci A., Yagci F., Ucak R. Verapamil prevents the apoptotic and hemodynamic changes in response to unilateral ureteral obstruction. Int J Urol 2008, 15(4):350-355.
57. Toblli J.E., Cao G., Giani J.F., Angerosa M., Dominici F.P., Gonzalez-Cadavid N.F. Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis. Kidney Blood Press Res 2010, 34(1):20-33.
58. Justo P., Sanz A.B., Sanchez-Nino M.D., Winkles J.A., Lorz C., Egido J., et al. Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int 2006, 70(10):1750-1758.
59. Strutz F., Zeisberg M., Hemmerlein B., Sattler B., Hummel K., Becker V., et al. Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. Kidney Int 2000, 57(4):1521-1538.
60. Lonnemann G., Shapiro L., Engler-Blum G., Muller G.A., Koch K.M., Dinarello C.A. Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts. Kidney Int 1995, 47(3):837-844.
61. Ong A.C., Fine L.G. Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: implications for human renal disease progression. Am J Kidney Dis 1994, 23(2):205-209.
62. Pandey S., Wang E. Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J Cell Biochem 1995, 58(2):135-150.
63. Gniadecki R., Hansen M., Wulf H.C. Two pathways for induction of apoptosis by ultraviolet radiation in cultured human keratinocytes. J Invest Dermatol 1997, 109(2):163-169.
64. Bozzo C., Tiberio R., Graziola F., Pertusi G., Valente G., Colombo E., et al. A Mycobacterium ulcerans toxin, mycolactone, induces apoptosis in primary human keratinocytes and in HaCaT cells. Microbes Infect 2010, 12(14-15):1258-1263.
65. Chevalier R.L., Forbes M.S., Thornhill B.A. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009, 75(11):1145-1152.
66. Manucha W. Biochemical-molecular markers in unilateral ureteral obstruction. Biocell 2007, 31(1):1-12.
67. Charruyer A., Barland C.O., Yue L., Wessendorf H.B., Lu Y., Lawrence H.J., et al. Transit-amplifying cell frequency and cell cycle kinetics are altered in aged epidermis. J Invest Dermatol 2009, 129(11):2574-2583.
68. Westhoff J.H., Schildhorn C., Jacobi C., Homme M., Hartner A., Braun H., et al. Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol 2010, 21(2):327-336.
69. Park J.Y., Park S.H., Weiss R.H. Disparate effects of roscovitine on renal tubular epithelial cell apoptosis and senescence: implications for autosomal dominant polycystic kidney disease. Am J Nephrol 2009, 29(6):509-515.
70. Megyesi J., Andrade L., Vieira J.M., Safirstein R.L., Price P.M. Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure. Am J Physiol Renal Physiol 2002, 283(4):F810-816.
71. Zhang Y., Yuan L., Fu L., Liu C., Liu D., Mei C. Overexpression of p18(INK4C) in LLC-PK1 cells increases resistance to cisplatin-induced apoptosis. Pediatr Nephrol 2011, 26(8):1291-1301.
72. Srisawat N., Manotham K., Eiam-Ong S., Katavetin P., Praditpornsilpa K. Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction?. Int J Urol 2008, 15(11):1011-1017.
73. Wei Q., Hill W.D., Su Y., Huang S., Dong Z. Heme oxygenase-1 induction contributes to renoprotection by G-CSF during rhabdomyolysis-associated acute kidney injury. Am J Physiol Renal Physiol 2011, 301(1):F162-70.
74. Chevalier R.L. Effects of ureteral obstruction on renal growth. Semin Nephrol 1995, 15(4):353-360.
75. Cao Z., Kelly D.J., Cox A., Casley D., Forbes J.M., Martinello P., et al. Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. Kidney Int 2000, 58(6):2437-2451.
76. Zhang S.L., Guo J., Moini B., Ingelfinger J.R. Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: impact on proliferation and apoptosis. Kidney Int 2004, 66(6):2181-2192.
77. Liu N., Tolbert E., Pang M., Ponnusamy M., Yan H., Zhuang S. Suramin inhibits renal fibrosis in chronic kidney disease. J Am Soc Nephrol 2011, 22(6):1064-1075.
78. Morath C., Zeier M. Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells. Int J Clin Pharmacol Ther 2003, 41(10):465-469.
79. Ysebaert D.K., De Greef K.E., Vercauteren S.R., Verhulst A., Kockx M., Verpooten G.A., et al. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury. Kidney Int 2003, 64(3):864-873.
80. Ventura C.G., Coimbra T.M., de Campos S.B., de Castro I., Yu L., Seguro A.C. Mycophenolate mofetil attenuates renal ischemia/reperfusion injury. J Am Soc Nephrol 2002, 13(10):2524-2533.
81. Morath C., Schwenger V., Beimler J., Mehrabi A., Schmidt J., Zeier M., et al. Antifibrotic actions of mycophenolic acid. Clin Transplant 2006, 20(Suppl 17):25-29.
82. Patsenker E., Schneider V., Ledermann M., Saegesser H., Dorn C., Hellerbrand C., et al. Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. J Hepatol 2010, 55(2):388-398.
83. Bridle K.R., Popa C., Morgan M.L., Sobbe A.L., Clouston A.D., Fletcher L.M., et al. Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways. Liver Transpl 2009, 15(10):1315-1324.
84. Wu M.J., Wen M.C., Chiu Y.T., Chiou Y.Y., Shu K.H., Tang M.J. Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int 2006, 69(11):2029-2036.
85. Tan X., Li Y., Liu Y. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 2006, 17(12):3382-3393.
86. Choi I.J., Kim S.Y., Kwon C.H., Kim Y.K. Rosiglitazone inhibits proliferation of renal proximal tubular cells via down-regulation of ERK and Akt. Ren Fail 2010, 32(1):103-111.
87. Obligado S.H., Ibraghimov-Beskrovnaya O., Zuk A., Meijer L., Nelson P.J. CDK/GSK-3 inhibitors as therapeutic agents for parenchymal renal diseases. Kidney Int 2008, 73(6):684-690.
88. Bukanov N.O., Smith L.A., Klinger K.W., Ledbetter S.R., Ibraghimov-Beskrovnaya O. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 2006, 444(7121):949-952.
89. Shankland S.J., Wolf G. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 2000, 278(4):F515-529.